Login to Your Account



Corus Pharma Applying $60M In Series C Funds To Development

By Aaron Lorenzo


Tuesday, April 13, 2004
Corus Pharma Inc. raised $60 million in its third round of private financing, among the largest recorded by a biotech company this year. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription